Lupher, Jr. Mark L. - Net Worth and Insider Trading

Lupher, Jr. Mark L. Net Worth

The estimated net worth of Lupher, Jr. Mark L. is at least $65,260 dollars as of 2024-12-27. Lupher, Jr. Mark L. is the Director of Adverum Biotechnologies Inc and owns about 13,000 shares of Adverum Biotechnologies Inc (ADVM) stock worth over $65,260. Details can be seen in Lupher, Jr. Mark L.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lupher, Jr. Mark L. has not made any transactions after 2024-02-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lupher, Jr. Mark L.

To

Lupher, Jr. Mark L. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lupher, Jr. Mark L. owns 1 companies in total, including Adverum Biotechnologies Inc (ADVM) .

Click here to see the complete history of Lupher, Jr. Mark L.’s form 4 insider trades.

Insider Ownership Summary of Lupher, Jr. Mark L.

Ticker Comapny Transaction Date Type of Owner
ADVM Adverum Biotechnologies Inc 2024-02-07 director

Lupher, Jr. Mark L. Latest Holdings Summary

Lupher, Jr. Mark L. currently owns a total of 1 stock. Lupher, Jr. Mark L. owns 13,000 shares of Adverum Biotechnologies Inc (ADVM) as of February 7, 2024, with a value of $65,260.

Latest Holdings of Lupher, Jr. Mark L.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADVM Adverum Biotechnologies Inc 2024-02-07 13,000 5.02 65,260

Holding Weightings of Lupher, Jr. Mark L.


Lupher, Jr. Mark L. Form 4 Trading Tracker

According to the SEC Form 4 filings, Lupher, Jr. Mark L. has made a total of 1 transactions in Adverum Biotechnologies Inc (ADVM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Adverum Biotechnologies Inc is the acquisition of 13,000 shares on February 7, 2024, which cost Lupher, Jr. Mark L. around $175,500.

Insider Trading History of Lupher, Jr. Mark L.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lupher, Jr. Mark L. Trading Performance

GuruFocus tracks the stock performance after each of Lupher, Jr. Mark L.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lupher, Jr. Mark L. is -63.2%. GuruFocus also compares Lupher, Jr. Mark L.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Lupher, Jr. Mark L. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lupher, Jr. Mark L.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lupher, Jr. Mark L.

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -31.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -34.92 LIMIT LIMIT LIMIT LIMIT LIMIT

Lupher, Jr. Mark L. Ownership Network

Ownership Network List of Lupher, Jr. Mark L.

No Data

Ownership Network Relation of Lupher, Jr. Mark L.

Insider Network Chart

Lupher, Jr. Mark L. Owned Company Details

What does Adverum Biotechnologies Inc do?

Who are the key executives at Adverum Biotechnologies Inc?

Lupher, Jr. Mark L. is the director of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .

Adverum Biotechnologies Inc (ADVM) Insider Trades Summary

Over the past 18 months, Lupher, Jr. Mark L. made 1 insider transaction in Adverum Biotechnologies Inc (ADVM) with a net purchase of 130,000. Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 302,064 shares made by Braden Michael Leonard , a net purchase of 100,000 shares made by James Paul Scopa , and a net sale of 6,201 shares made by Setareh Seyedkazemi .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 620 shares of Adverum Biotechnologies Inc (ADVM) were sold and 325,064 shares were bought by its insiders, resulting in a net purchase of 324,444 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adverum Biotechnologies Inc Insider Transactions

No Available Data

Lupher, Jr. Mark L. Mailing Address

Above is the net worth, insider trading, and ownership report for Lupher, Jr. Mark L.. You might contact Lupher, Jr. Mark L. via mailing address: C/o Adverum Biotechnologies, Inc., 1035 O'brien Drive, Menlo Park Ca 94025.

Discussions on Lupher, Jr. Mark L.

No discussions yet.